Starpharma Holdings Ltd banner

Intrinsic Value

The intrinsic value of Starpharma Holdings Ltd (SPHRF) under the Base Case is 0.26 USD per share. Compared with the current market price of 0.58 USD, the stock appears Overvalued by 55% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

SPHRF Intrinsic Value
$0.26
Overvaluation 55%
Intrinsic Value
Price $0.58

We don’t have enough historical valuation data to make this comparison.

Monitor SPHRF
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $0.21
Get notified when the price drops into your buy zone
Current Price $0.58
Intrinsic Value $0.26
Margin of Safety 20% $0.21
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to SPHRF

Fundamental Analysis

What Starpharma Does

Pharmaceuticals Health Care

Starpharma Holdings Ltd is a biotechnology company that develops and commercializes dendrimer-based products. Its best-known products are its antiviral and antibacterial gels and coatings, including women’s health products and disinfectant or surface-treatment technologies. In simple terms, it uses its chemistry platform to make products that can block germs or carry active ingredients in a more targeted way.

Headquarters
Australia AU
Employees
50
IPO date
Sep 28, 2000
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Starpharma Holdings Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one SPHRF stock?

The intrinsic value for Starpharma Holdings Ltd (SPHRF) under the Base Case is 0.26 USD.

Is SPHRF stock undervalued or overvalued?

Compared with the current market price of 0.58 USD, the stock appears Overvalued by 55% .

Back to Top